Silence Therapeutics' Lead RNA Interference Therapeutic Prevents Spread Of Cancer To Lungs

Links shared publicly online about this topic.

  • 735
    total visits

Silence Therapeutics' Lead RNA Interference Therapeutic Prevents Spread Of Cancer To Lungs

medicalnewstoday.com

Silence Therapeutics plc (AIM: SLN) (Silence or the Company) announces positive research findings demonstrating the ability of the Company's lead RNA interference (RNAi) drug candidate, Atu027

View full resource at medicalnewstoday.com

Tags: Cancer, Lung, Drug

  • Share

Most Recently Shared on November 11, 2010 at 9:05 pm By:

mnt_genetics MNT Genetics News

Silence Therapeutics' Lead RNA Interference Therapeutic Prevents Spread Of Cancer To Lungs http://mnt.to/3MqG #genetics

1 year ago...

Also Shared By:

MNT Asthma News MNT Asthma News

MNT Lung Cancer MNT Lung Cancer

MNT Biology News MNT Biology News

Silence Therapeutics' Lead RNA Interference Therapeutic Prevents Spread Of Cancer To Lungs - QualityPoint Technologies

qualitypointtech.net — “Silence Therapeutics plc (AIM: SLN) (View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on November 11, 2010 at 5:34 pm By:

MedicalFeed MedicalFeed Health News Feed

Silence Therapeutics' Lead RNA Interference Therapeutic Prevents Spread Of Cancer To Lungs: Silence Therapeutics ... http://bit.ly/9RLXWf

1 year ago...

Advertisement